Barclay A Phillips - Net Worth and Insider Trading
Barclay A Phillips Net Worth
The estimated net worth of Barclay A Phillips is at least $7,529 dollars as of 2024-04-19. Barclay A Phillips is the SVP, CFO of Novavax Inc and owns about 1,933 shares of Novavax Inc (NVAX) stock worth over $7,529. Barclay A Phillips is also the SVP & CFO of G1 Therapeutics Inc and owns about 0 shares of G1 Therapeutics Inc (GTHX) stock worth over $0. Details can be seen in Barclay A Phillips's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Barclay A Phillips has not made any transactions after 2018-11-15 and currently still holds the listed stock(s).
Transaction Summary of Barclay A Phillips
Barclay A Phillips Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Barclay A Phillips owns 4 companies in total, including Immunic Inc () , G1 Therapeutics Inc () , and Novavax Inc () among others .
Click here to see the complete history of Barclay A Phillips’s form 4 insider trades.
Insider Ownership Summary of Barclay A Phillips
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| Immunic Inc | 2019-11-18 | director | |
| G1 Therapeutics Inc | 2018-11-15 | SVP & Chief Financial Officer | |
| Novavax Inc | 2017-07-31 | director | |
| Acorda Therapeutics Inc | 2006-02-09 | director |
Barclay A Phillips Latest Holdings Summary
Barclay A Phillips currently owns a total of 2 stocks. Among these stocks, Barclay A Phillips owns 1,933 shares of Novavax Inc (NVAX) as of July 31, 2017, with a value of $7,529 and a weighting of 100%. Barclay A Phillips also owns 0 shares of G1 Therapeutics Inc (GTHX) as of November 15, 2018, with a value of $0 and a weighting of 0%.
Latest Holdings of Barclay A Phillips
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| NVAX | Novavax Inc | 2017-07-31 | 1,933 | 3.90 | 7,529 |
| GTHX | G1 Therapeutics Inc | 2018-11-15 | 0 | 4.16 | 0 |
Holding Weightings of Barclay A Phillips
Barclay A Phillips Form 4 Trading Tracker
According to the SEC Form 4 filings, Barclay A Phillips has made a total of 0 transactions in Novavax Inc (NVAX) over the past 5 years. The most-recent trade in Novavax Inc is the acquisition of 103 shares on July 31, 2017, which cost Barclay A Phillips around $1,831.
According to the SEC Form 4 filings, Barclay A Phillips has made a total of 0 transactions in G1 Therapeutics Inc (GTHX) over the past 5 years. The most-recent trade in G1 Therapeutics Inc is the sale of 5,000 shares on November 15, 2018, which brought Barclay A Phillips around $199,600.
Insider Trading History of Barclay A Phillips
- 1
Barclay A Phillips Trading Performance
GuruFocus tracks the stock performance after each of Barclay A Phillips's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Barclay A Phillips is -1.46%. GuruFocus also compares Barclay A Phillips's trading performance to market benchmark return within the same time period. The performance of stocks bought by Barclay A Phillips within 3 months outperforms 6 times out of 11 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Barclay A Phillips's insider trading performs compared to the benchmark.
Performance of Barclay A Phillips
Average Return
42.28%
Outperforming Transactions
73%
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 7.44 | -1.46 | 22.75 | 42.28 | -9.58 | -15.73 |
| Relative Return to S&P 500(%) | 5.98 | -4.94 | 16.22 | 29.89 | -19.12 | -25.27 |
Barclay A Phillips Ownership Network
Ownership Network List of Barclay A Phillips
Ownership Network Relation of Barclay A Phillips
Barclay A Phillips Owned Company Details
What does Immunic Inc do?
Who are the key executives at Immunic Inc?
Barclay A Phillips is the director of Immunic Inc. Other key executives at Immunic Inc include director & CEO & President Daniel Vitt , PAO and Controller Glenn Whaley , and Chief Medical Officer Andreas Muehler .
Immunic Inc () Insider Trades Summary
Over the past 18 months, Barclay A Phillips made no insider transaction in Immunic Inc (). Other recent insider transactions involving Immunic Inc () include a net purchase of 100,000 shares made by Joerg Neermann , a net purchase of 22,000 shares made by Daniel Vitt , and a net purchase of 10,000 shares made by Glenn Whaley .
In summary, during the past 3 months, insiders sold 0 shares of Immunic Inc () in total and bought 14,000 shares, with a net purchase of 14,000 shares. During the past 18 months, 0 shares of Immunic Inc () were sold and 132,000 shares were bought by its insiders, resulting in a net purchase of 132,000 shares.
Immunic Inc ()'s detailed insider trading history can be found in Insider Trading Tracker table.
Immunic Inc Insider Transactions
Barclay A Phillips Mailing Address
Above is the net worth, insider trading, and ownership report for Barclay A Phillips. You might contact Barclay A Phillips via mailing address: C/o Cancer Vax Corp, 2110 Rutherford Road, Carlsbad Ca 92008.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
